Navigation Links
Universite de Montreal and Validapro Biosciences Inc. have Signed an Agreement-in-Principle
Date:5/19/2009

Universite de Montreal and Validapro Biosciences Inc. have signed an agreement-in-principle to ensure the valorization and the operation under cGMP standards of the biotherapeutic manufacturing unit located at the Faculty of veterinary medicine in St-Hyacinthe, Quebec, Canada, for human and veterinary clinical use.

Laval, Quebec (PRWEB) May 18, 2009 -- Universite de Montreal and Validapro Biosciences Inc. have signed an agreement-in-principle to ensure the valorization and the operation under cGMP standards of the biotherapeutic manufacturing unit located at the Faculty of veterinary medicine in St-Hyacinthe, Quebec, Canada, for human and veterinary clinical use.

Validapro Biosciences Inc. via its division Laborium Biopharma will utilize the clinical scale bioproduction site for research and development projects as well as for commercial applications.

This agreement demonstrates the will of Validapro Biosciences Inc. to pursue its corporative growth strategy by the development of its Global Services Center to meet the needs of the Life Sciences industry. This represents phase 2 of the creation of its clinical biomanufacturing unit operating under the strictest regulatory requirements. Through this agreement, Universite de Montreal as well as its researchers and partners, get access to these services meeting the international standards.

###

Read the full story at http://www.prweb.com/releases/2009/05/prweb2433924.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1

Related biology technology :

1. Sigma-Aldrich and the Universite de Montreal Establish Collaboration for RNA Interference Studies
2. Immtech to Present at The Bank of Montreal Healthcare Conference
3. Bionovo to Present at Bank of Montreals 2007 Focus on Healthcare Conference
4. YM BIOSCIENCES REPORTS THIRD QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS
5. Frost & Sullivan Awards Precision Biosciences for Technology Innovation and Molecular Design Process in the Genomics Market
6. Neurocrine Biosciences to Present at the Deutsche Bank 34th Annual Health Care Conference
7. MichBio Leader Cites New Senate Biosciences Task Force and House Subcommittee as Evidence of States Growing Awareness of Industrys Economic Importance
8. Neurocrine Biosciences Reports First Quarter 2009 Results
9. Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research
10. Sangamo BioSciences Announces Publication in Nature of the Use of Zinc Finger Nucleases to Accelerate Precision Trait Stacking in Commercial Crop Species
11. ImQuest BioSciences and Arisyn Therapeutics Announce Strategic Partnership to Develop Infectious Disease and Cancer Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Universite de Montreal and Validapro Biosciences Inc. have Signed an Agreement-in-Principle
(Date:4/20/2017)... TIKVAH, Israel , April 20, 2017 /PRNewswire/ ... adult stem cell technologies for neurodegenerative diseases, announced today that ... the Alliance for Regenerative Medicine,s (ARM) 5 th Annual ... 2017 at 09:40 EDT in Boston . ... MHSc, Chief Medical Officer & Chief Operating Officer, will participate ...
(Date:4/19/2017)... ... April 18, 2017 , ... ... has been a key device for generating monodisperse droplets of known diameters for ... and for generating monodisperse solid particles by drying monodisperse droplets. , The ...
(Date:4/19/2017)... ... ... Alisa Wright, founder and CEO of Singota Solutions , has received ... Lafayette, Indiana. , The Distinguished Alumni Award was established in 1984 to honor ... endeavors. , Wright began her career in the pharmaceutical industry with firms such ...
(Date:4/19/2017)... , ... April 19, 2017 , ... Nobilis Therapeutics ... , Company Seeks to Leverage Clinical Data in its Upcoming Post Traumatic Stress Disorder ... of an 81 patient clinical trial assessing efficacy of its NBTX-001, a xenon-based therapeutic ...
Breaking Biology Technology:
(Date:3/29/2017)...  higi, the health IT company that operates the ... , today announced a Series B investment from ... The new investment and acquisition accelerates higi,s strategy to ... population health activities through the collection and workflow integration ... collects and secures data today on behalf of over ...
(Date:3/27/2017)... ROCKVILLE CENTRE, N.Y. , March 27, 2017 ... by Healthcare Information and Management Systems Society (HIMSS) ... Analytics Outpatient EMR Adoption Model sm . In ... top 12% of U.S. hospitals using an electronic ... recognized CHS for its high level of EMR ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Industry Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access ... 15.1% over the next decade to reach approximately $1,580 million by ... and forecasts for all the given segments on global as well ...
Breaking Biology News(10 mins):